Cargando…
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555969/ https://www.ncbi.nlm.nih.gov/pubmed/34746843 http://dx.doi.org/10.1016/S2665-9913(21)00321-0 |
| _version_ | 1784592085428469760 |
|---|---|
| author | Della-Torre, Emanuel Criscuolo, Elena Lanzillotta, Marco Locatelli, Massimo Clementi, Nicola Mancini, Nicasio Dagna, Lorenzo |
| author_facet | Della-Torre, Emanuel Criscuolo, Elena Lanzillotta, Marco Locatelli, Massimo Clementi, Nicola Mancini, Nicasio Dagna, Lorenzo |
| author_sort | Della-Torre, Emanuel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8555969 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-85559692021-11-01 IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 Della-Torre, Emanuel Criscuolo, Elena Lanzillotta, Marco Locatelli, Massimo Clementi, Nicola Mancini, Nicasio Dagna, Lorenzo Lancet Rheumatol Comment Elsevier Ltd. 2021-12 2021-10-29 /pmc/articles/PMC8555969/ /pubmed/34746843 http://dx.doi.org/10.1016/S2665-9913(21)00321-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Della-Torre, Emanuel Criscuolo, Elena Lanzillotta, Marco Locatelli, Massimo Clementi, Nicola Mancini, Nicasio Dagna, Lorenzo IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 |
| title | IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 |
| title_full | IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 |
| title_fullStr | IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 |
| title_full_unstemmed | IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 |
| title_short | IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19 |
| title_sort | il-1 and il-6 inhibition affects the neutralising activity of anti-sars-cov-2 antibodies in patients with covid-19 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555969/ https://www.ncbi.nlm.nih.gov/pubmed/34746843 http://dx.doi.org/10.1016/S2665-9913(21)00321-0 |
| work_keys_str_mv | AT dellatorreemanuel il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 AT criscuoloelena il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 AT lanzillottamarco il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 AT locatellimassimo il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 AT clementinicola il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 AT mancininicasio il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 AT dagnalorenzo il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 AT il1andil6inhibitionaffectstheneutralisingactivityofantisarscov2antibodiesinpatientswithcovid19 |